{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:36:43Z","timestamp":1761561403190},"reference-count":11,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2010,2,8]],"date-time":"2010-02-08T00:00:00Z","timestamp":1265587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2010,4]]},"abstract":"<jats:sec><jats:label \/><jats:p> <jats:italic>Aliment Pharmacol Ther<\/jats:italic>\u2002<jats:bold>31<\/jats:bold>, 846\u2013851<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Over\u2010the\u2010counter (OTC) proton pump inhibitors (PPIs) relieve heartburn by decreasing the production of gastric acid, but may not do so with equal effectiveness. It is important for healthcare professionals to compare the ability of OTC PPIs to control gastric acid when recommending them for patients with frequent heartburn.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To compare the effects of omeprazole\u2010Mg 20.6\u2003mg and lansoprazole 15\u2003mg (OTC doses in the US) on 24\u2010h steady state gastric acid suppression.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> This single\u2010centre, randomized, double\u2010blind clinical study compared the steady\u2010state gastric acid control of omeprazole\u2010Mg 20.6\u2003mg vs. lansoprazole 15\u2003mg, dosed before breakfast. Volunteers were enrolled in a 3\u2010period, cross\u2010over design (ABB, BAA) with 24\u2010h gastric pH monitoring on dosing day 5. The primary efficacy variable was the percentage time intragastric pH was &gt;4.0 over 24\u2003h on day 5 of dosing.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Forty subjects were enrolled; all completed the study. The mean (SE) percentage time pH was &gt;4.0 was 45.7% (3.45%) for omeprazole\u2010Mg 20.6\u2003mg and 36.8% (3.45%) for lansoprazole 15\u2003mg, an absolute difference of 8.9% (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001), and a relative difference of 24.2%. Both drugs were well tolerated.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> Omeprazole\u2010Mg 20.6\u2003mg provided a statistically significantly (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001) greater acid control than lansoprazole 15\u2003mg.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2010.04258.x","type":"journal-article","created":{"date-parts":[[2010,2,8]],"date-time":"2010-02-08T14:59:57Z","timestamp":1265641197000},"page":"846-851","source":"Crossref","is-referenced-by-count":10,"title":["Omeprazole\u2010Mg 20.6\u2003mg is superior to lansoprazole 15\u2003mg for control of gastric acid: a comparison of over\u2010the\u2010counter doses of proton pump inhibitors"],"prefix":"10.1111","volume":"31","author":[{"suffix":"JR","given":"P. B.","family":"MINER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. A.","family":"MCKEAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. D.","family":"GIBB","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. N.","family":"ERASALA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. L.","family":"RAMSEY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. W.","family":"MCRORIE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,3,17]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(01)02580-1"},{"key":"e_1_2_6_3_2","first-page":"98","article-title":"Profile of consumers in need: people with sour stomachs, by demographics","volume":"74","author":"AC Nielsen\/SmithKlineBeecham Survey","year":"1995","journal-title":"Progressive Groc"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03129.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.05.021"},{"key":"e_1_2_6_6_2","volume-title":"Cross\u2010over Experiments: Design, Analysis, and Application","author":"Ratkowsky DA","year":"1993"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.08783.x"},{"key":"e_1_2_6_8_2","first-page":"17S","article-title":"Optimizing the pharmacology of acid control in acid\u2010related disorder","volume":"92","author":"Howden CW","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-008-0576-5"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.09.012"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199703000-00003"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(97)80053-7"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2010.04258.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2010.04258.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T09:42:35Z","timestamp":1698745355000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2010.04258.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,17]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["10.1111\/j.1365-2036.2010.04258.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2010.04258.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,17]]}}}